Artera to Address MMAI Risk Stratification,Treatment Decisions in Cancer
- Posted on May 22, 2026
- By Google News
- 0 Views
- 1 min read
Artera to Address MMAI Risk Stratification,Treatment Decisions in Cancer
May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present multiple abstracts at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, May 29–June 2, in Chicago.